HEADER BIOSYNTHETIC PROTEIN 24-AUG-23 8TXY
TITLE X-RAY CRYSTAL STRUCTURE OF JRD-SIK1/2I-3 BOUND TO A MARK2-SIK2 CHIMERA
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE MARK2;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: ELKL MOTIF KINASE 1,EMK-1,MAP/MICROTUBULE AFFINITY-
COMPND 5 REGULATING KINASE 2,PAR1 HOMOLOG,PAR1 HOMOLOG B,PAR-1B,PAR1B;
COMPND 6 EC: 2.7.11.1,2.7.11.26;
COMPND 7 ENGINEERED: YES;
COMPND 8 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: MARK2, EMK1;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008
KEYWDS KINASE, ENZYME, CHIMERA, INHIBITOR, BIOSYNTHETIC PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR D.D.RAYMOND,C.T.LEMKE,P.L.SHAFFER,B.COLLINS,R.STEELE,M.SEIERSTAD
REVDAT 2 20-NOV-24 8TXY 1 REMARK
REVDAT 1 10-JAN-24 8TXY 0
JRNL AUTH H.BABBE,T.B.SUNDBERG,M.TICHENOR,M.SEIERSTAD,G.BACANI,
JRNL AUTH 2 J.BERSTLER,W.CHAI,L.CHANG,M.CHUNG,K.COE,B.COLLINS,M.FINLEY,
JRNL AUTH 3 A.GULETSKY,C.T.LEMKE,P.A.MAK,A.MATHUR,E.V.MERCADO-MARIN,
JRNL AUTH 4 S.METKAR,D.D.RAYMOND,M.L.RIVES,M.RIZZOLIO,P.L.SHAFFER,
JRNL AUTH 5 R.SMITH,J.SMITH,R.STEELE,H.STEFFENS,J.SUAREZ,G.TIAN,
JRNL AUTH 6 N.MAJEWSKI,L.P.VOLAK,J.WEI,P.T.DESAI,L.L.ONG,T.KOUDRIAKOVA,
JRNL AUTH 7 S.D.GOLDBERG,G.HIRST,V.K.KAUSHIK,T.ORT,N.SETH,D.B.GRAHAM,
JRNL AUTH 8 S.PLEVY,J.D.VENABLE,R.J.XAVIER,J.E.TOWNE
JRNL TITL IDENTIFICATION OF HIGHLY SELECTIVE SIK1/2 INHIBITORS THAT
JRNL TITL 2 MODULATE INNATE IMMUNE ACTIVATION AND SUPPRESS INTESTINAL
JRNL TITL 3 INFLAMMATION.
JRNL REF PROC.NATL.ACAD.SCI.USA V. 121 86120 2024
JRNL REFN ESSN 1091-6490
JRNL PMID 38147543
JRNL DOI 10.1073/PNAS.2307086120
REMARK 2
REMARK 2 RESOLUTION. 2.10 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.10.4 (8-JUN-2022)
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.50
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 3 NUMBER OF REFLECTIONS : 48682
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.241
REMARK 3 R VALUE (WORKING SET) : 0.239
REMARK 3 FREE R VALUE : 0.267
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : 2435
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.12
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.80
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL
REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : 0.3676
REMARK 3 BIN FREE R VALUE : 0.4354
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 49
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4972
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 88
REMARK 3 SOLVENT ATOMS : 100
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 61.63
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 2.03960
REMARK 3 B22 (A**2) : 2.03960
REMARK 3 B33 (A**2) : -4.07920
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.360
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.205
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.176
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.216
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.182
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.910
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 5244 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 7134 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 1895 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL
REMARK 3 GENERAL PLANES : 912 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 5166 ; 10.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 638 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 4008 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.008
REMARK 3 BOND ANGLES (DEGREES) : 0.91
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.93
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.56
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 8TXY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-AUG-23.
REMARK 100 THE DEPOSITION ID IS D_1000276896.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 18-JUN-19
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 6.8
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : XSCALE
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48682
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 200 DATA REDUNDANCY : 10.20
REMARK 200 R MERGE (I) : 0.05000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.6000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20
REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0
REMARK 200 DATA REDUNDANCY IN SHELL : 10.20
REMARK 200 R MERGE FOR SHELL (I) : 2.00000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.300
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 58.98
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 24% PEG 400, 150 MM LISO4, 100 MM MES
REMARK 280 PH 6.8, VAPOR DIFFUSION, TEMPERATURE 298K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z+1/3
REMARK 290 3555 -X+Y,-X,Z+2/3
REMARK 290 4555 -X,-Y,Z+1/2
REMARK 290 5555 Y,-X+Y,Z+5/6
REMARK 290 6555 X-Y,X,Z+1/6
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 33.21333
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 66.42667
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 49.82000
REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 83.03333
REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 16.60667
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLN A 47
REMARK 465 GLY A 197
REMARK 465 ASN A 198
REMARK 465 GLU A 199
REMARK 465 PHE A 200
REMARK 465 THR A 201
REMARK 465 PHE A 202
REMARK 465 GLY A 203
REMARK 465 ASN A 204
REMARK 465 LYS A 205
REMARK 465 LEU A 206
REMARK 465 ASP A 207
REMARK 465 PHE B 196
REMARK 465 GLY B 197
REMARK 465 ASN B 198
REMARK 465 GLU B 199
REMARK 465 PHE B 200
REMARK 465 THR B 201
REMARK 465 PHE B 202
REMARK 465 GLY B 203
REMARK 465 ASN B 204
REMARK 465 LYS B 205
REMARK 465 LEU B 206
REMARK 465 ASP B 207
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ARG A 174 -3.22 70.64
REMARK 500 ASP A 175 37.83 -141.59
REMARK 500 ASP A 193 92.69 66.32
REMARK 500 ARG B 174 -3.82 70.44
REMARK 500 ASP B 175 38.02 -140.82
REMARK 500 ASP B 193 87.06 67.77
REMARK 500
REMARK 500 REMARK: NULL
DBREF 8TXY A 47 363 UNP Q7KZI7 MARK2_HUMAN 47 363
DBREF 8TXY B 47 363 UNP Q7KZI7 MARK2_HUMAN 47 363
SEQADV 8TXY LEU A 59 UNP Q7KZI7 ILE 59 ENGINEERED MUTATION
SEQADV 8TXY VAL A 66 UNP Q7KZI7 LYS 66 ENGINEERED MUTATION
SEQADV 8TXY ILE A 81 UNP Q7KZI7 VAL 81 ENGINEERED MUTATION
SEQADV 8TXY ILE A 97 UNP Q7KZI7 LEU 97 ENGINEERED MUTATION
SEQADV 8TXY ILE A 113 UNP Q7KZI7 VAL 113 ENGINEERED MUTATION
SEQADV 8TXY THR A 129 UNP Q7KZI7 MET 129 ENGINEERED MUTATION
SEQADV 8TXY LYS A 133 UNP Q7KZI7 SER 133 ENGINEERED MUTATION
SEQADV 8TXY ASN A 134 UNP Q7KZI7 GLY 134 ENGINEERED MUTATION
SEQADV 8TXY GLY A 197 UNP Q7KZI7 SER 197 ENGINEERED MUTATION
SEQADV 8TXY LEU B 59 UNP Q7KZI7 ILE 59 ENGINEERED MUTATION
SEQADV 8TXY VAL B 66 UNP Q7KZI7 LYS 66 ENGINEERED MUTATION
SEQADV 8TXY ILE B 81 UNP Q7KZI7 VAL 81 ENGINEERED MUTATION
SEQADV 8TXY ILE B 97 UNP Q7KZI7 LEU 97 ENGINEERED MUTATION
SEQADV 8TXY ILE B 113 UNP Q7KZI7 VAL 113 ENGINEERED MUTATION
SEQADV 8TXY THR B 129 UNP Q7KZI7 MET 129 ENGINEERED MUTATION
SEQADV 8TXY LYS B 133 UNP Q7KZI7 SER 133 ENGINEERED MUTATION
SEQADV 8TXY ASN B 134 UNP Q7KZI7 GLY 134 ENGINEERED MUTATION
SEQADV 8TXY GLY B 197 UNP Q7KZI7 SER 197 ENGINEERED MUTATION
SEQRES 1 A 317 GLN PRO HIS ILE GLY ASN TYR ARG LEU LEU LYS THR LEU
SEQRES 2 A 317 GLY LYS GLY ASN PHE ALA VAL VAL LYS LEU ALA ARG HIS
SEQRES 3 A 317 ILE LEU THR GLY LYS GLU VAL ALA ILE LYS ILE ILE ASP
SEQRES 4 A 317 LYS THR GLN LEU ASN SER SER SER LEU GLN LYS ILE PHE
SEQRES 5 A 317 ARG GLU VAL ARG ILE MET LYS VAL LEU ASN HIS PRO ASN
SEQRES 6 A 317 ILE ILE LYS LEU PHE GLU VAL ILE GLU THR GLU LYS THR
SEQRES 7 A 317 LEU TYR LEU VAL THR GLU TYR ALA LYS ASN GLY GLU VAL
SEQRES 8 A 317 PHE ASP TYR LEU VAL ALA HIS GLY ARG MET LYS GLU LYS
SEQRES 9 A 317 GLU ALA ARG ALA LYS PHE ARG GLN ILE VAL SER ALA VAL
SEQRES 10 A 317 GLN TYR CYS HIS GLN LYS PHE ILE VAL HIS ARG ASP LEU
SEQRES 11 A 317 LYS ALA GLU ASN LEU LEU LEU ASP ALA ASP MET ASN ILE
SEQRES 12 A 317 LYS ILE ALA ASP PHE GLY PHE GLY ASN GLU PHE THR PHE
SEQRES 13 A 317 GLY ASN LYS LEU ASP THR PHE CYS GLY SER PRO PRO TYR
SEQRES 14 A 317 ALA ALA PRO GLU LEU PHE GLN GLY LYS LYS TYR ASP GLY
SEQRES 15 A 317 PRO GLU VAL ASP VAL TRP SER LEU GLY VAL ILE LEU TYR
SEQRES 16 A 317 THR LEU VAL SER GLY SER LEU PRO PHE ASP GLY GLN ASN
SEQRES 17 A 317 LEU LYS GLU LEU ARG GLU ARG VAL LEU ARG GLY LYS TYR
SEQRES 18 A 317 ARG ILE PRO PHE TYR MET SER THR ASP CYS GLU ASN LEU
SEQRES 19 A 317 LEU LYS LYS PHE LEU ILE LEU ASN PRO SER LYS ARG GLY
SEQRES 20 A 317 THR LEU GLU GLN ILE MET LYS ASP ARG TRP MET ASN VAL
SEQRES 21 A 317 GLY HIS GLU ASP ASP GLU LEU LYS PRO TYR VAL GLU PRO
SEQRES 22 A 317 LEU PRO ASP TYR LYS ASP PRO ARG ARG THR GLU LEU MET
SEQRES 23 A 317 VAL SER MET GLY TYR THR ARG GLU GLU ILE GLN ASP SER
SEQRES 24 A 317 LEU VAL GLY GLN ARG TYR ASN GLU VAL MET ALA THR TYR
SEQRES 25 A 317 LEU LEU LEU GLY TYR
SEQRES 1 B 317 GLN PRO HIS ILE GLY ASN TYR ARG LEU LEU LYS THR LEU
SEQRES 2 B 317 GLY LYS GLY ASN PHE ALA VAL VAL LYS LEU ALA ARG HIS
SEQRES 3 B 317 ILE LEU THR GLY LYS GLU VAL ALA ILE LYS ILE ILE ASP
SEQRES 4 B 317 LYS THR GLN LEU ASN SER SER SER LEU GLN LYS ILE PHE
SEQRES 5 B 317 ARG GLU VAL ARG ILE MET LYS VAL LEU ASN HIS PRO ASN
SEQRES 6 B 317 ILE ILE LYS LEU PHE GLU VAL ILE GLU THR GLU LYS THR
SEQRES 7 B 317 LEU TYR LEU VAL THR GLU TYR ALA LYS ASN GLY GLU VAL
SEQRES 8 B 317 PHE ASP TYR LEU VAL ALA HIS GLY ARG MET LYS GLU LYS
SEQRES 9 B 317 GLU ALA ARG ALA LYS PHE ARG GLN ILE VAL SER ALA VAL
SEQRES 10 B 317 GLN TYR CYS HIS GLN LYS PHE ILE VAL HIS ARG ASP LEU
SEQRES 11 B 317 LYS ALA GLU ASN LEU LEU LEU ASP ALA ASP MET ASN ILE
SEQRES 12 B 317 LYS ILE ALA ASP PHE GLY PHE GLY ASN GLU PHE THR PHE
SEQRES 13 B 317 GLY ASN LYS LEU ASP THR PHE CYS GLY SER PRO PRO TYR
SEQRES 14 B 317 ALA ALA PRO GLU LEU PHE GLN GLY LYS LYS TYR ASP GLY
SEQRES 15 B 317 PRO GLU VAL ASP VAL TRP SER LEU GLY VAL ILE LEU TYR
SEQRES 16 B 317 THR LEU VAL SER GLY SER LEU PRO PHE ASP GLY GLN ASN
SEQRES 17 B 317 LEU LYS GLU LEU ARG GLU ARG VAL LEU ARG GLY LYS TYR
SEQRES 18 B 317 ARG ILE PRO PHE TYR MET SER THR ASP CYS GLU ASN LEU
SEQRES 19 B 317 LEU LYS LYS PHE LEU ILE LEU ASN PRO SER LYS ARG GLY
SEQRES 20 B 317 THR LEU GLU GLN ILE MET LYS ASP ARG TRP MET ASN VAL
SEQRES 21 B 317 GLY HIS GLU ASP ASP GLU LEU LYS PRO TYR VAL GLU PRO
SEQRES 22 B 317 LEU PRO ASP TYR LYS ASP PRO ARG ARG THR GLU LEU MET
SEQRES 23 B 317 VAL SER MET GLY TYR THR ARG GLU GLU ILE GLN ASP SER
SEQRES 24 B 317 LEU VAL GLY GLN ARG TYR ASN GLU VAL MET ALA THR TYR
SEQRES 25 B 317 LEU LEU LEU GLY TYR
HET PEG A 401 17
HET PEG A 402 17
HET SJ0 A 403 55
HET SO4 A 404 5
HET PEG B 401 17
HET SJ0 B 402 55
HETNAM PEG DI(HYDROXYETHYL)ETHER
HETNAM SJ0 N-[(5P,8R)-5-(2-CYANO-5-{[(3R)-1-METHYLPYRROLIDIN-3-
HETNAM 2 SJ0 YL]METHOXY}PYRIDIN-4-YL)PYRAZOLO[1,5-A]PYRIDIN-2-
HETNAM 3 SJ0 YL]CYCLOPROPANECARBOXAMIDE
HETNAM SO4 SULFATE ION
FORMUL 3 PEG 3(C4 H10 O3)
FORMUL 5 SJ0 2(C23 H24 N6 O2)
FORMUL 6 SO4 O4 S 2-
FORMUL 9 HOH *100(H2 O)
HELIX 1 AA1 THR A 87 LEU A 89 5 3
HELIX 2 AA2 SER A 92 LEU A 107 1 16
HELIX 3 AA3 GLU A 136 GLY A 145 1 10
HELIX 4 AA4 LYS A 148 LYS A 169 1 22
HELIX 5 AA5 LYS A 177 GLU A 179 5 3
HELIX 6 AA6 SER A 212 ALA A 216 5 5
HELIX 7 AA7 ALA A 217 GLY A 223 1 7
HELIX 8 AA8 PRO A 229 GLY A 246 1 18
HELIX 9 AA9 ASN A 254 GLY A 265 1 12
HELIX 10 AB1 SER A 274 LEU A 285 1 12
HELIX 11 AB2 ASN A 288 ARG A 292 5 5
HELIX 12 AB3 THR A 294 MET A 299 1 6
HELIX 13 AB4 LYS A 300 ASP A 301 5 2
HELIX 14 AB5 ARG A 302 VAL A 306 5 5
HELIX 15 AB6 ASP A 325 GLY A 336 1 12
HELIX 16 AB7 THR A 338 GLY A 348 1 11
HELIX 17 AB8 ASN A 352 LEU A 361 1 10
HELIX 18 AB9 THR B 87 LEU B 89 5 3
HELIX 19 AC1 SER B 92 LEU B 107 1 16
HELIX 20 AC2 GLU B 136 GLY B 145 1 10
HELIX 21 AC3 LYS B 148 LYS B 169 1 22
HELIX 22 AC4 LYS B 177 GLU B 179 5 3
HELIX 23 AC5 SER B 212 ALA B 216 5 5
HELIX 24 AC6 ALA B 217 GLN B 222 1 6
HELIX 25 AC7 PRO B 229 GLY B 246 1 18
HELIX 26 AC8 ASN B 254 GLY B 265 1 12
HELIX 27 AC9 SER B 274 LEU B 285 1 12
HELIX 28 AD1 ASN B 288 ARG B 292 5 5
HELIX 29 AD2 THR B 294 MET B 299 1 6
HELIX 30 AD3 LYS B 300 ASP B 301 5 2
HELIX 31 AD4 ARG B 302 VAL B 306 5 5
HELIX 32 AD5 ASP B 325 GLY B 336 1 12
HELIX 33 AD6 THR B 338 GLY B 348 1 11
HELIX 34 AD7 ASN B 352 LEU B 361 1 10
SHEET 1 AA1 6 HIS A 49 ILE A 50 0
SHEET 2 AA1 6 TYR A 53 GLY A 60 -1 O TYR A 53 N ILE A 50
SHEET 3 AA1 6 ALA A 65 HIS A 72 -1 O LEU A 69 N LYS A 57
SHEET 4 AA1 6 GLU A 78 ASP A 85 -1 O ILE A 81 N LYS A 68
SHEET 5 AA1 6 THR A 124 GLU A 130 -1 O THR A 129 N ALA A 80
SHEET 6 AA1 6 LEU A 115 GLU A 120 -1 N PHE A 116 O VAL A 128
SHEET 1 AA2 2 LEU A 181 LEU A 183 0
SHEET 2 AA2 2 ILE A 189 ILE A 191 -1 O LYS A 190 N LEU A 182
SHEET 1 AA3 6 HIS B 49 ILE B 50 0
SHEET 2 AA3 6 TYR B 53 GLY B 60 -1 O TYR B 53 N ILE B 50
SHEET 3 AA3 6 ALA B 65 HIS B 72 -1 O LEU B 69 N LYS B 57
SHEET 4 AA3 6 GLU B 78 ASP B 85 -1 O ILE B 83 N VAL B 66
SHEET 5 AA3 6 THR B 124 THR B 129 -1 O LEU B 125 N ILE B 84
SHEET 6 AA3 6 LEU B 115 GLU B 120 -1 N PHE B 116 O VAL B 128
SHEET 1 AA4 2 LEU B 181 LEU B 183 0
SHEET 2 AA4 2 ILE B 189 ILE B 191 -1 O LYS B 190 N LEU B 182
SSBOND 1 CYS A 210 CYS B 210 1555 1555 2.04
CRYST1 121.430 121.430 99.640 90.00 90.00 120.00 P 61 12
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.008235 0.004755 0.000000 0.00000
SCALE2 0.000000 0.009509 0.000000 0.00000
SCALE3 0.000000 0.000000 0.010036 0.00000